CYCCP Projected Dividend Yield

Pfd Conv Exchangeable 6%/Bio Green Med Solution Inc ( NASDAQ : CYCCP )

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic program is evaluating plogosertib, in solid tumors and hematological malignancies.

11 YEAR PERFORMANCE RESULTS

CYCCP Dividend History Detail
CYCCP Dividend News
CYCCP Competitors News

# of Shares: 0

Closing Price: 1.44

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2025	0.15	0%	0	$ 0.00	0.00%
2026	0.60	0%	0	$ 0.00	41.67%
2027	0.30	0%	0	$ 0.00	41.67%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 41.67%
Rolling Last 4 qtrs dividends total $ 0.30 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.30 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2026	Jan 12, 2026	Jan 22, 2026	Jan 22, 2026	Feb 01, 2026	0.1500
2026 Total:					0.1500
2025	Oct 07, 2025	Oct 20, 2025	Oct 20, 2025	Nov 01, 2025	0.1500
2025 Total:					0.1500